[HTML] nature.com

[HTML][HTML] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley… - British journal of …, 2018 - nature.com
Abstract Background In Study 19, maintenance monotherapy with olaparib significantly
prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent …
被引用次数：174 相关文章

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib …

M Friedlander, U Matulonis… - British Journal of …, 2018 - scholars.northwestern.edu
Background: In Study 19, maintenance monotherapy with olaparib significantly prolonged
progression-free survival vs placebo in patients with platinum-sensitive, recurrent high …
[PDF] kuleuven.be

[PDF][PDF] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley, A du Bois… - 2018 - lirias.kuleuven.be
BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly
prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent …
[PDF] ed.ac.uk

[PDF][PDF] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley… - British Journal of …, 2018 - research.ed.ac.uk
BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly
prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent …

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib …

M Friedlander, U Matulonis, C Gourley… - British journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background In Study 19, maintenance monotherapy with olaparib significantly prolonged
progression-free survival vs placebo in patients with platinum-sensitive, recurrent high …
[HTML] nih.gov

[HTML][HTML] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley… - British Journal of …, 2018 - ncbi.nlm.nih.gov
Background In Study 19, maintenance monotherapy with olaparib significantly prolonged
progression-free survival vs placebo in patients with platinum-sensitive, recurrent high …

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib …

M Friedlander, U Matulonis, C Gourley… - British Journal of …, 2018 - discovery.ucl.ac.uk
BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly
prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent …
[PDF] core.ac.uk

[PDF][PDF] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley, A du Bois… - 2018 - core.ac.uk
BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly
prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent …

[引用][C] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley, A du Bois… - British Journal of …, 2018 - elibrary.ru
Medical writing support during the development of this manuscript was provided by Elin
Pyke, MChem from Mudskipper Business Ltd and was funded by AstraZeneca. MF is …
[PDF] ed.ac.uk

[PDF][PDF] Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance …

M Friedlander, U Matulonis, C Gourley, A du Bois… - 2018 - pure.ed.ac.uk
BACKGROUND: In Study 19, maintenance monotherapy with olaparib significantly
prolonged progression-free survival vs placebo in patients with platinum-sensitive, recurrent …